Global Endobronchial Ultrasound Biopsy Devices Market, By Product (Biopsy Forceps, Cytology Brushes, Biopsy Needles, Trans bronchial Aspiration Needles, Spray Catheters, Others), Application (Cancer Diagnosis, Infection Diagnosis, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
The endobronchial ultrasound biopsy devices market is expected to witness market growth at a rate of 4.43% in the forecast period of 2021 to 2028 and is expected to reach USD 842.44 million by 2028. Data Bridge Market Research report on endobronchial ultrasound biopsy devices market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The expansion of the healthcare sector is escalating the growth of the endobronchial ultrasound biopsy devices market.
Endobronchial ultrasound (EBUS) refers to the type of ultrasound technique utilized to diagnose stage lung cancer and determine how far the disease has spread to other parts of the body, such as the lymph nodes. This kind of ultrasound refers to a minimally invasive technique to collect tissue samples for biopsy.
The increase in the prevalence of lung cancer among the population across the globe acts as one of the major factors driving the growth of the endobronchial ultrasound biopsy devices market. The rise in demand for minimally invasive medical procedures and high adoption of the procedure by interventional radiologists and the diagnostic department to determine diseases for a healthcare institution such as medical clinics, and diagnostic centers, among others, accelerate the market growth. The rise in awareness regarding early diagnosis and its benefits among people and high usage of the biopsy to diagnose cancer and help distinguish healthy cells or calluses from tumorous cells further influence the market.
In addition, unhealthy lifestyle, the surge in healthcare expenditure, growing number of cancer awareness campaigns, growing population, and rise in awareness about various diseases positively affect the endobronchial ultrasound biopsy devices market. Furthermore, technological advancement in the ultrasound process extends profitable opportunities to the market players in the forecast period of 2021 to 2028.
On the other hand, a rise in the concerns regarding the biopsy-related risk of infections is expected to obstruct the market growth. The uncertain regulatory norms and policies are projected to challenge the endobronchial ultrasound biopsy devices market in the forecast period of 2021-2028.
This endobronchial ultrasound biopsy devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on endobronchial ultrasound biopsy devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Endobronchial Ultrasound Biopsy Devices Market Scope and Market Size
The endobronchial ultrasound biopsy devices market is segmented on the basis of product and application. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the endobronchial ultrasound biopsy devices market is segmented into biopsy forceps, cytology brushes, biopsy needles, trans bronchial aspiration needles, spray catheters and others.
- On the basis of application, the endobronchial ultrasound biopsy devices market is segmented into cancer diagnosis, infection diagnosis, and others.
Global Endobronchial Ultrasound Biopsy Devices Market Country Level Analysis
The endobronchial ultrasound biopsy devices market is analyzed, and market size insights and trends are provided by country, product, and application as referenced above.
The countries covered in the global endobronchial ultrasound biopsy devices market report are the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the endobronchial ultrasound biopsy devices market because of well-developed healthcare infrastructure, skilled professionals, and technological advancements within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the rising prevalence of lung cancer in the region.
The country section of the endobronchial ultrasound biopsy devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The endobronchial ultrasound biopsy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for endobronchial ultrasound biopsy devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on endobronchial ultrasound biopsy devices market. The data is available for the historic period 2010-2019.
Competitive Landscape and Endobronchial Ultrasound Biopsy Devices Market Share Analysis
The endobronchial ultrasound biopsy devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the endobronchial ultrasound biopsy devices market.
The major players covered in the endobronchial ultrasound biopsy devices market report are BD, Cook Group, Devicor Medical Products, Inc., ARGON MEDICAL, SOMATEX Medical Technologies GmbH, Scion Medical Technologies, LLC, UROMED Kurt Drews KG, STERYLAB S.r.l, DTR Medical Ltd, EndoMed Systems Alle Rechte vorbehalten, CONMED Corporation, TSK Laboratory Europe B.V, ZAMAR CARE, B. Braun Melsungen AG, Cardinal Health, Siemens, General Electric Company, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Olympus Corporation, Medtronic, and SRL Diagnostics, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.